Intellectual Property India Publishes Patent Application for 'Opioid Receptor Agonist And Use Thereof' Filed by Chengdu Aoda Biotechnology Co. Ltd.

MUMBAI, India, Nov. 7 -- Intellectual Property India has published a patent application (202547095800 A) filed by Chengdu Aoda Biotechnology Co. Ltd., Sichuan, China, on Oct. 6, for 'opioid receptor agonist and use thereof.'

Inventor(s) include Zhou, Shuliang; Wang, Peng; and Deng, Lan.

The application for the patent was published on Nov. 7, under issue no. 45/2025.

According to the abstract released by the Intellectual Property India: "A ? opioid receptor agonist and a stereoisomer and pharmaceutically acceptable salt thereof, having the following structural formula and relating to the technical field of biological medicines. The ? opioid receptor agonist has high selectivity to a ? opioid receptor, the activity of the ? opioid receptor agonist is 3-15 times that of Difelikefalin, the drug activity is high, and the ? opioid receptor agonist can be used for treating and/or relieving pruritus and/or analgesia. D-Phe-AA1-AA2-D-Lys-4-aminopiperidine-4-carboxamide-AA3-AA4-AA5 (Formula I)."

The patent application was internationally filed on Apr. 03, 2024, under International application No.PCT/CN2024/085849.

Disclaimer: Curated by HT Syndication.